|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/55 | (2006.01) |
| A61P 25/14 | (2006.01) | ||
| A61K 31/519 | (2006.01) |
| (11) | Number of the document | 3057595 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14854586.6 |
| Date of filing the European patent application | 2014-10-17 | |
| (97) | Date of publication of the European application | 2016-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-29 |
| (46) | Date of publication of the claims translation | 2020-08-10 |
| (86) | Number | PCT/US2014/061080 |
| Date | 2014-10-17 |
| (87) | Number | WO 2015/058053 |
| Date | 2015-04-23 |
| (30) | Number | Date | Country code |
| 201361892841 P | 2013-10-18 | US |
| (72) |
CHIPKIN, Richard E., US
|
| (73) |
Emalex Biosciences, Inc.,
330 N Wabash, Suite 3500, Chicago, IL 60611,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Sintezuoti benzazepinai, skirti mikčiojimui gydyti |
| FUSED BENZAZEPINES FOR TREATMENT OF STUTTERING |
| Payment date | Validity (years) | Amount | |
| 2025-09-19 | 12 | 289.00 EUR |
| 2026-10-17 |